With expansion a prime focus for businesses worldwide, many are looking towards rapidly establishing new regions of growth, particularly in Asia, Pacifi c Rim countries.
To appear in our next issue, send your Business and Financial News stories to
heather@intlabmate.com The latest business developments from across Europe & Middle East
Animal Diagnostics Specialist Opens First Subsidiary in the UK
existing UK customer base and entering into new business relationships with UK-based customers.
“We are very enthusiastic about the creation of our fi rst subsidiary. It is important for us to get closer to our UK customers and provide them with a dedicated sales team. I am very pleased to welcome Lauren onboard. She is a highly experienced manager in the veterinary sales fi eld with the cross-functional capabilities to easily adapt to Enalees’ free-management mindset,” said Laurent Thiery, President and co-founder of the Evry, France-based company.
The UK veterinary diagnostics market is expected to witness rapid growth over the 2022-2027 forecast period and is projected to register a CAGR of 9.5% according to analyst’s Mordor Intelligence (1)
Lauren Craig
Animal health provision-focused Enalees, a company specialising in the design, development, production and marketing of rapid molecular diagnostic tests and LAMP PCR (Loop-mediated isothermal AMPlifi cation Polymerase Chain Reaction) has announced the establishment of its fi rst European subsidiary in North Yorkshire, UK. The move signifi es the fi rst step towards creating a European group effort to supporting veterinary professionals’ dedicated to improving animal welfare.
Lauren Craig, General Manager UK & ROI, at Enalees, has been appointed as head of the UK subsidiary. She has ten years’ experience in sales with an extensive record in the distribution of innovative veterinary solutions, including executive sales positions at Jorgen Krusse and Covetrus. In her new role, she will be responsible for growing the
“As part of Enalees’ expansion plans, I will be coordinating the launch of the UK subsidiary and working with veterinary professionals to deliver Enalees’ unique portfolio offering in diagnostic testing and in clinic rapid PCR tests,” added Lauren Craig. “I am incredibly excited for the challenge ahead and looking forward to working with a fantastic team with an important mission in this key market.”
Enalees offers a variety of POC tests for many canine, feline and equine infectious diseases, which offer capability for detection of a virus, parasite or microbe at a very early stage. Employing 32 staff it recorded €1.5 million ($1.47 million) in sales in 2021 which equated to 66% growth.
1. United Kingdom Veterinary Healthcare Market –Growth, Trends, COVID-19 Impact and Forecasts (2022-2027). Mordor Intelligence Report
More information online:
ilmt.co/PL/O9Wz 59478pr@reply-direct.com
by Heather Hobbs
This section of International Labmate will especially look at the success of both Asian and European companies with established premises or business partnerships, highlighting the opportunities that exist while realising
potential for other companies to move into export markets.
Investment Round to Push Fluorescent Dyes to Market
University of Birmingham (Credit: University of Birmingham)
A second round equity investment of £487k towards the end of 2022, is enabling University of Birmingham spin-out ChromaTwist Ltd to continue development of its new class of fl uorescent dyes destined for the fl ow cytometry reagent market, which with its current growth rate has been estimated to reach a value of $2.9Bn by 2027. The funding will help facilitation of industry partnerships to advance development of products which could potentially reach the marketplace as soon as 2023, said the company.
Bovine Pneumonia Test Supports on-Farm Interpretation Approach
Social enterprise Global Access Diagnostics (GADx) has joined a collaboration that will take forward the development of RaDiCal, a one-step molecular lateral fl ow test to enable rapid diagnosis of pneumonia, particularly in calves. One of the most signifi cant diseases affecting calves, pneumonia costs the UK cattle industry an estimated £50 million a year (1).
Including representatives from the University of Surrey, University of Glasgow, Cardiff University and Westpoint Farm Vets, the consortium is combining expertise in microbiology, veterinary infectious disease and diagnostic test development to create the new test, which can be linked to a mobile phone digital platform for easy interpretation of results. This will enable farmers and vets to diagnose calves on-farm and subsequently take rapid and informed action to facilitate improved disease management and support responsible antibiotic stewardship.
The project, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), follows GADx’s participation in a BBSRC Endemic Livestock Disease Priming Partnerships workshop and was driven by challenges outlined by farmers,
Dr Alison Wakeham, Head of Agriculture and Animal Health, GADx, said: “GADx’s expertise in lateral fl ow technology allows us to support a variety of disease areas. By applying our platform within the livestock industry, we are glad to be able to help improve disease management for one of the most signifi cant diseases affecting calves.
Working alongside other experts in this fi eld through the consortium and with the support of BBSRC funding, we are looking forward to progressing the project and bringing the transformative test to market. Being able to accurately diagnose and treat early in the disease cycle is critical to prevent spread and control outbreaks.”
Professor Mark Chambers, Professor of Microbiology and Disease Intervention, University of Surrey, who is leading the project, commented: “The University of Surrey is delighted to be leading the RaDiCal project and will be using its experience of veterinary infectious diseases and test development within an exciting consortium of other academics and representatives from industry, large animal veterinary practice and farmers themselves at the sharp end of managing calf pneumonia. Through this close partnership and on-going consultation we shall ensure we develop a test that meets the needs of the cattle industry.”
In support of this research, the University of Surrey’s School of Veterinary Medicine is looking for veterinary surgeons who work with calves to share their experiences of using diagnostic tests and managing calf pneumonia.
More information online:
ilmt.co/PL/g1X4
1. Agriculture and Horticulture Development Board more information online:
ilmt.co/PL/Z4nK 59479pr@reply-direct.com
The dyes, said to show exceptional versatility with a large range of ‘signalling colours’ with potential for conducting simultaneous tests on a single sample, were discovered by the research groups led by Professor Jon Preece from the University’s School of Chemistry and Professor Alex Robinson from the School of Chemical Engineering, during a programme of research into photo-conducting liquid crystals. With a unique chemistry allowing tuneable fl uorescence, small adjustments made to the molecular structure of these materials would alter the colour of the light they emit, from blue through to red and potentially into the infra-red. The technology is protected by patents owned by the company.
The funding builds on initial grant funding of £347k from Innovate UK, £90k funding from the Directors in 2019, and a fi rst equity funding round of £430k from directors, Angel investors and the University of Birmingham in 2021.
Professor Jon Preece commented: “Following a year of rapid product development and customer engagement, we have now moved to our own dedicated laboratory and will be expanding our team of scientists so we can expedite our dye development for fl ow cytometry. We expect the resulting dyes to be fully compatible with existing fl ow cytometry processes and equipment and are looking forward to the next 12 months working with industry partners.”
Founders Preece and Robinson have already worked together on existing spinout, Irresistible Materials Ltd, which develops organic materials for new lithographic processes including e-beam and EUV lithography. ChromaTwist’s management team will including Chairman, Mark Shepherd (also CEO Irresistible Materials Ltd), with extensive knowledge in licensing and spin out companies and Darren Wake, who has three decades of executive level experience including M&A.
It is also evaluating longer-term opportunities in other sectors, including security inks and applications in organic electronics. Having already sold 18 of its dyes to Sigma- Aldrich, part of the Life Science business sector of Merck, it is open to initial discussion with other businesses about potential partnerships and collaborations in these areas.
More information online:
ilmt.co/PL/La35 59477pr@reply-direct.com
Business
Opportunities
Europe & Middle East
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
